Healthcare / Medical Care FacilitiesTokyo
$816.00
-23.00 (-2.72%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $86.9M · quality 33.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.5B
P/E
11.9x
↓EV/EBITDA
6.0x
↓ROE
10.5%
↑Gross Margin
31.1%
↓Debt/Equity
0.91
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.2%
FCF CAGR
—
FCF margin
1.0%
FCF / Net income
0.68x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $9.03B · net income $128.3M · FCF $86.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.03B | $9.03B | $9.91B | $10.03B | $9.65B |
| Net Income | $128.3M | $128.3M | $172.3M | $153.3M | $105.1M |
| EBITDA | $230.0M | $230.0M | $263.8M | $256.1M | $175.2M |
| EPS | 68.85 | 68.85 | 88.20 | 84.24 | 87.88 |
| Gross Margin | 31.1% | 31.1% | 27.9% | 28.4% | 26.7% |
| Operating Margin | 2.5% | 2.5% | 2.5% | 2.4% | 1.7% |
| Net Margin | 1.4% | 1.4% | 1.7% | 1.5% | 1.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.91 | 0.91 | 0.68 | 0.93 | 1.94 |
| Current Ratio | 1.42 | 1.42 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $86.9M | $86.9M | $160.2M | $-256.0M | $-227.0M |
| Returns | |||||
| ROE | 10.5% | 10.5% | 15.3% | 16.4% | 23.1% |
| Valuation | |||||
| P/E | 11.85 | 11.85 | 10.24 | 17.83 | — |
| EV/EBITDA | 5.95 | 5.95 | 6.17 | 10.79 | — |
| P/B | 1.24 | 1.24 | 1.57 | 2.92 | — |
| Growth & Yield | |||||
| Revenue Growth | -8.8% | -8.8% | -1.2% | 3.9% | — |
| EPS Growth | -21.9% | -21.9% | 4.7% | -4.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
1.7%
EPS terminal req.
$72.41
Spread vs growth
-23.6%
5Y implied EPS CAGR
4.9%
EPS terminal req.
$87.61
Spread vs growth
-26.9%
10Y implied EPS CAGR
7.4%
EPS terminal req.
$141.10
Spread vs growth
-29.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+7.2%
Start / end P/E
8.7x → 11.9x
EPS bridge
88.20 → 68.85
Residual
-8.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.